GLOBAL NEUROSTIMULATION DEVICE MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

GLOBAL NEUROSTIMULATION DEVICE MARKET 2019-2027

Market By System, Applications, And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The detailed analysis of the global neurostimulation device market shows that in terms of revenue, the market is estimated to grow at a CAGR of 10.23% during the forecasting years 2019-2027. The market is expected to generate a revenue of $11899.1 million by the year 2027. The implantable devices used for neuromodulation are referred to as neurostimulation devices or neurostimulators.

Report scope can be customized per your requirements. Request For Customization

Neurostimulation is a potential alternative for individuals unresponsive to drug therapy or surgeries. Neurostimulation devices help in the therapeutic activation of the nervous system. These implantable devices send electrical stimuli to the brain, spinal cord, and other organs, playing an integral function in the nervous system. The neurostimulator sends a target-specific stimulus that inhibits the passage of pain signals to the brain. Healthcare experts use these devices to treat various neurological disorders such as epilepsy, pain, depression, Parkinson’s disease, obsessive-compulsive disorder, dystonia, and tremor, which will likely boost the neurostimulation device market.

The study aims to get an overview of the neurostimulation device market in terms of various factors. Within this report, the market definition and the key insights regarding the neurostimulation device market have been discussed. Also, the value chain outlook, market trends, market share outlook, Pestle outlook, and market attractiveness index have been studied in detail.

Market drivers like the rising incidence of neuro diseases, increasing geriatric population, growing demand for MRI scans, and favorable reimbursement policies are driving the neurostimulation device market growth. However, the market is facing market restraints like the high cost of neuromodulation treatment and the presence of alternative therapy, which are obstructing the market growth.

Key opportunities like the high market potential for SCS devices in neurostimulation, technological development, and growing incidence of chronic discomfort can be leveraged by the market to reach the projected growth. However, challenges such as stringent regulatory approvals and side-effects of associated neurostimulation devices are being faced by this market.

To get detailed insights on segments, Download Sample Report

Geographies covered in the neurostimulation device market by region are:

•    North America: The United States and Canada

•    Asia-Pacific: China, Japan, India, South Korea, Australia & New Zealand, ASEAN countries and Rest of Asia-Pacific

•    Europe: The United Kingdom, Germany, Italy, Russia, Spain, France and Rest of Europe

•    Latin America: Brazil, Mexico and Rest of Latin America

•    Middle East & Africa: Turkey, the United Arab Emirates, South Africa, Saudi Arabia, and the Rest of Middle East & Africa

The neurostimulation device market has been segmented as follows:

•    By System

O    Spinal cord stimulators

O    Gastric electric stimulator

O    Sacral nerve stimulators

O    Deep brain stimulators

O    Vagus nerve stimulators

O    Other systems

•    By Application

O    Gastroparesis

O    Pain management

O    Depression

O    Parkinson’s disease

O    Epilepsy

O    Essential tremor

O    Urinary and fecal incontinence

O    Dystonia

O    Other applications

The key players engaged in the neurostimulation device market are Aleva Neurotherapeutics SA, Boston Scientific Corporation, Cogentix Medical, Inc., Cyberonics, Inc., DePuy Synthes Companies, Dr. Langer Medical GmbH, Ectron Limited, Ekso Bionics Holding Inc., Helius Medical Technologies, Hocoma AG, Medtronic plc, Neuronetics, Inc., Nevro Corp., St. Jude Medical, Inc. (acquired by Abbott Laboratories) and The Magstim Company Limited.

The strategic analysis for each of these companies has been covered in detail. The neurostimulation device market by company share helps to dive into the information about the key market players in this market and how much hold they have on the market.


Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL NEUROSTIMULATION DEVICE MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES MODEL

2.2.1.   THREAT OF NEW ENTRANTS

2.2.2.   THREAT OF SUBSTITUTES

2.2.3.   BARGAINING POWER OF SUPPLIERS

2.2.4.   BARGAINING POWER OF BUYERS

2.2.5.   THREAT OF RIVALRY

2.3. VALUE CHAIN OUTLOOK

2.4. MARKET TRENDS

2.5. MARKET SHARE OUTLOOK

2.6. PESTLE OUTLOOK

2.7. MARKET ATTRACTIVENESS INDEX

2.8. KEY INSIGHT

2.9. MARKET DRIVERS

2.9.1.   RISING INCIDENCE OF NEURO DISEASES

2.9.2.   INCREASING GERIATRIC POPULATION

2.9.3.   GROWING DEMAND FOR MRI SCANS

2.9.4.   FAVORABLE REIMBURSEMENT POLICIES

2.10.            MARKET RESTRAINTS

2.10.1.                HIGH COST OF NEUROMODULATION TREATMENT

2.10.2.                PRESENCE OF ALTERNATIVE THERAPY

2.11.            MARKET OPPORTUNITIES

2.11.1.                HIGH MARKET POTENTIAL FOR SCS DEVICES IN NEUROSTIMULATION

2.11.2.                TECHNOLOGICAL DEVELOPMENT

2.11.3.                GROWING INCIDENCE OF CHRONIC DISCOMFORT

2.12.            MARKET CHALLENGES

2.12.1.                STRINGENT REGULATORY APPROVALS

2.12.2.                SIDE-EFFECTS ASSOCIATED WITH NEUROSTIMULATION DEVICES

3.    NEUROSTIMULATION DEVICE MARKET OUTLOOK – BY SYSTEM

3.1. SPINAL CORD STIMULATORS (SCS)

3.2. DEEP BRAIN STIMULATORS (DBS)

3.3. SACRAL NERVE STIMULATORS (SNS)

3.4. VAGUS NERVE STIMULATORS (VNS)

3.5. GASTRIC ELECTRIC STIMULATOR

3.6. OTHER SYSTEMS

4.    NEUROSTIMULATION DEVICE MARKET OUTLOOK – BY APPLICATIONS

4.1. PAIN MANAGEMENT

4.2. EPILEPSY

4.3. ESSENTIAL TREMOR

4.4. URINARY AND FECAL INCONTINENCE

4.5. DEPRESSION

4.6. DYSTONIA

4.7. GASTROPARESIS

4.8. PARKINSON’S DISEASE

4.9. OTHER APPLICATIONS

5.    NEUROSTIMULATION DEVICE MARKET – REGIONAL OUTLOOK

5.1. NORTH AMERICA

5.1.1.   MARKET BY SYSTEM

5.1.2.   MARKET BY APPLICATION

5.1.3.   COUNTRY ANALYSIS

5.1.3.1.      THE UNITED STATES

5.1.3.2.      CANADA

5.2. EUROPE

5.2.1.   MARKET BY SYSTEM

5.2.2.   MARKET BY APPLICATION

5.2.3.   COUNTRY ANALYSIS

5.2.3.1.      THE UNITED KINGDOM

5.2.3.2.      FRANCE

5.2.3.3.      GERMANY

5.2.3.4.      SPAIN

5.2.3.5.      ITALY

5.2.3.6.      RUSSIA

5.2.3.7.      REST OF EUROPE

5.3. ASIA-PACIFIC

5.3.1.   MARKET BY SYSTEM

5.3.2.   MARKET BY APPLICATION

5.3.3.   COUNTRY ANALYSIS

5.3.3.1.      INDIA

5.3.3.2.      CHINA

5.3.3.3.      JAPAN

5.3.3.4.      AUSTRALIA & NEW ZEALAND

5.3.3.5.      SOUTH KOREA

5.3.3.6.      ASEAN COUNTRIES

5.3.3.7.      REST OF ASIA-PACIFIC

5.4. LATIN AMERICA

5.4.1.   MARKET BY SYSTEM

5.4.2.   MARKET BY APPLICATION

5.4.3.   COUNTRY ANALYSIS

5.4.3.1.      BRAZIL

5.4.3.2.      MEXICO

5.4.3.3.      REST OF LATIN AMERICA

5.5. MIDDLE EAST AND AFRICA

5.5.1.   MARKET BY SYSTEM

5.5.2.   MARKET BY APPLICATION

5.5.3.   COUNTRY ANALYSIS

5.5.3.1.      SAUDI ARABIA

5.5.3.2.      TURKEY

5.5.3.3.      THE UNITED ARAB EMIRATES

5.5.3.4.      SOUTH AFRICA

5.5.3.5.      REST OF MIDDLE EAST & AFRICA

6.    COMPANY PROFILES

6.1. NEURONETICS, INC.

6.2. ST. JUDE MEDICAL, INC. (ACQUIRED BY ABBOTT LABORATORIES)

6.3. HOCOMA AG

6.4. NEVRO CORP.

6.5. CYBERONICS INC.

6.6. COGENTIX MEDICAL, INC.

6.7. DEPUY SYNTHES COMPANIES

6.8. DR. LANGER MEDICAL GMBH

6.9. MEDTRONIC PLC

6.10.            THE MAGSTIM COMPANY LIMITED

6.11.            ECTRON LIMITED

6.12.            BOSTON SCIENTIFIC CORPORATION

6.13.            EKSO BIONICS HOLDINGS INC.

6.14.            ALEVA NEUROTHERAPEUTICS SA

6.15.            HELIUS MEDICAL TECHNOLOGIES

7.    RESEARCH METHODOLOGY & SCOPE

7.1. RESEARCH SCOPE & DELIVERABLES

7.1.1.   OBJECTIVES OF STUDY

7.1.2.   SCOPE OF STUDY

7.2. SOURCES OF DATA

7.2.1.   PRIMARY DATA SOURCES

7.2.2.   SECONDARY DATA SOURCES

7.3. RESEARCH METHODOLOGY

7.3.1.   EVALUATION OF PROPOSED MARKET

7.3.2.   IDENTIFICATION OF DATA SOURCES

7.3.3.   ASSESSMENT OF MARKET DETERMINANTS

7.3.4.   DATA COLLECTION

7.3.5.   DATA VALIDATION & ANALYSIS

            

List of table

TABLE 1        GLOBAL NEUROSTIMULATION DEVICE MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 3        GLOBAL NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 4        GLOBAL NEUROSTIMULATION DEVICE MARKET BY GEOGRAPHY 2019-2027 (IN $ MILLION)

TABLE 5        NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 6        NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 7        CONDITIONS TREATED BY NEUROSTIMULATION DEVICES IN THE UNITED STATES

TABLE 8        NORTH AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 9        EUROPE NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 10      EUROPE NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 11      EUROPE NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 12      ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 13      ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 14      ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 15      LATIN AMERICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 16      LATIN AMERICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 17      LATIN AMERICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 18      MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY SYSTEM 2019-2027 ($ MILLION)

TABLE 19      MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY APPLICATIONS 2019-2027 ($ MILLION)

TABLE 20      MIDDLE EAST AND AFRICA NEUROSTIMULATION DEVICE MARKET BY COUNTRY 2019-2027 ($ MILLION)                     

List of Figures

FIGURE 1      GLOBAL NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 2      VALUE CHAIN OUTLOOK

FIGURE 3      PREVALENCE OF MENTAL HEALTH DISORDERS 2012 AND 2020 (MILLION)

FIGURE 4      RISING GERIATRIC POPULATION ACROSS THE GLOBE FOR PERIOD 2014-2020 (MILLION)

FIGURE 5      NEUROSTIMULATION DEVICE COMPANY MARKET SHARE OUTLOOK 2018 (%)

FIGURE 6      GLOBAL NEUROSTIMULATION DEVICE MARKET BY SPINAL CORD STIMULATORS 2019-2027 ($ MILLION)

FIGURE 7      GLOBAL NEUROSTIMULATION DEVICE MARKET BY DEEP BRAIN STIMULATORS 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL NEUROSTIMULATION DEVICE MARKET BY SACRAL NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL NEUROSTIMULATION DEVICE MARKET BY VAGUS NERVE STIMULATORS 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL NEUROSTIMULATION DEVICE MARKET BY GASTRIC ELECTRIC STIMULATOR 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL NEUROSTIMULATION DEVICE MARKET BY OTHER SYSTEM 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL NEUROSTIMULATION DEVICE MARKET BY PAIN MANAGEMENT 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL NEUROSTIMULATION DEVICE MARKET BY EPILEPSY 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL NEUROSTIMULATION DEVICE MARKET BY ESSENTIAL TREMOR 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL NEUROSTIMULATION DEVICE MARKET BY URINARY AND FECAL INCONTINENCE 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL NEUROSTIMULATION DEVICE MARKET BY DEPRESSION 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL NEUROSTIMULATION DEVICE MARKET BY DYSTONIA 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL NEUROSTIMULATION DEVICE MARKET BY GASTROPARESIS 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL NEUROSTIMULATION DEVICE MARKET BY PARKINSON’S DISEASE 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL NEUROSTIMULATION DEVICE MARKET BY OTHER APPLICATIONS 2019-2027 ($ MILLION)

FIGURE 21   THE UNITED STATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 22   CANADA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 23   THE UNITED KINGDOM NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 24   FRANCE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 25   GERMANY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 26   SPAIN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 27   ITALY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 28   RUSSIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 29   REST OF EUROPE NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 30   INDIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 31   CHINA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 32   JAPAN NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 33   AUSTRALIA & NEW ZEALAND NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 34   SOUTH KOREA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 35   ASEAN COUNTRIES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 36   REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 37   BRAZIL NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 38   MEXICO NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 39   REST OF LATIN AMERICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 40   SAUDI ARABIA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 41   TURKEY NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 42   THE UNITED ARAB EMIRATES NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 43   SOUTH AFRICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)

FIGURE 44   REST OF MIDDLE EAST & AFRICA NEUROSTIMULATION DEVICE MARKET 2019-2027 ($ MILLION)    

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;